⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Clorox CLX

United States Consumer Defensive
4.8/10
AI Analyst score
83.80 USD
Last price at analysis date · analyst target 100.76 (+20.2%)
🛒 Where to buy CLXPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold or reduce: balance sheet and dividend cut risk outweigh the current dividend yield appeal.

Clorox is a consumer products company for home and health, with brands like Clorox, Pine-Sol, and Glad, selling through retailers and distribution channels worldwide. Clorox shows a highly leveraged balance sheet (ND/EBITDA 4.79, liquidity 0.66) and a contracting business (earnings -50%), with a 5.97% dividend not covered by the 103% payout. Underlying quality (42% gross margin, 15% ROIC) does not offset balance sheet and dividend cut risk.

Financial health
2.2
Quality / Moat
6.0
Valuation
5.6
Growth
1.4
Dividend
4.9
Momentum
2.5
Risk & Context
7.8

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E17.42
Fwd P/E13.39
EV/EBITDA13.82
P/B112.63
P/S1.51
PEG1.05
Market cap10.13 B USD
Enterprise value15.75 B USD
🏰 Quality and moat
ROIC (approx.)15.2%
Gross margin42.32%
FCF conversion10%
Operating margin12.88%
📈 Profitability and margins
ROE163.76%
ROA8.32%
Net margin8.73%
FCF110.4 M USD
FCF yield1.09%
🏦 Solvency and liquidity
Total debt5.60 B USD
Net debt5.46 B USD
Cash143.0 M USD
EBITDA1.14 B USD
Net debt / EBITDA4.79
D/E2221.43
Current ratio0.66
Quick ratio0.34
🚀 Growth
Revenue growth-2.00%
Earnings growth-50.10%
EPS (TTM)4.81 USD
EPS (Fwd)6.26 USD
💰 Dividend and risk
Dividend yield5.97%
Payout103.1%
Beta0.54
Analyst consensusHold (17)
Target price100.76 USD
52-week range81.60 USD – 128.90 USD
⚠️ Main risk: Extreme leverage (Debt/Equity 2221%) combined with a 103% payout and earnings falling 50% makes a dividend cut or equity raise highly likely, which would destroy the income investment thesis.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Clorox is a consumer products company for home and health, with brands like Clorox, Pine-Sol, and Glad, selling through retailers and distribution channels worldwide. Clorox shows a highly leveraged balance sheet (ND/EBITDA 4.79, liquidity 0.66) and a contracting business (earnings -50%), with a 5.97% dividend not covered by the 103% payout. Underlying quality (42% gross margin, 15% ROIC) does not offset balance sheet and dividend cut risk.

Score by category

CategoryScore
Financial health2.2
Quality / Moat6.0
Valuation5.6
Growth1.4
Dividend4.9
Momentum2.5
Risk & Context7.8

OVERALL SCORE: 4.8/10

Context and risks

The 103% payout and 50% earnings decline make the 5.97% dividend unsustainable without a cut, a risk the market already partially discounts. The high-rate context (10Y at 5.17%) is not the dominant factor for a defensive consumer company with this balance sheet structure.

News considered in the analysis

  • 2 Mid-Cap Stocks on Our Watchlist and 1 We Find Risky — Listículo genérico sin información específica nueva sobre Clorox.
  • The Clorox Company Stock: Is CLX Underperforming the Consumer Staples Sector? — Comparativa de rendimiento sectorial sin datos concretos que alteren la valoración.
  • Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive? — Noticia sobre un competidor (P&G), no sobre Clorox; sin impacto directo.
  • Clorox vs. Kimberly-Clark: Which Household Staples Dividend Is Safer — Análisis comparativo de dividendos sin hechos nuevos; el payout de Clorox ya es conocido.
  • These 6 Massive Dividend Yields May Be Too Good to Be True — Advierte sobre la sostenibilidad de dividendos muy altos; relevante para Clorox dado su payout del 103%.

Verdict: Hold or reduce: balance sheet and dividend cut risk outweigh the current dividend yield appeal.

Main risk: Extreme leverage (Debt/Equity 2221%) combined with a 103% payout and earnings falling 50% makes a dividend cut or equity raise highly likely, which would destroy the income investment thesis.

Other Consumer Defensive companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.